Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioPlus Specialty Pharmacy is a leading provider of specialty pharmacy and home infusion services, specializing in the management of complex, chronic conditions. The company offers a comprehensive suite of services including clinical monitoring, patient education, and rapid referral processing, notably featuring a 2-hour turnaround for patient acceptance. Their therapeutic focus spans oncology, neurology, immunology, and infectious diseases, providing access to limited distribution drugs and biologics. In 2023, BioPlus was acquired by Elevance Health to be integrated into its Carelon health services brand, enhancing its ability to provide end-to-end specialty medication management. The organization operates multiple centers of excellence and ambulatory infusion suites across the United States to support patient care. By leveraging advanced technology and clinical expertise, BioPlus aims to improve medication adherence and health outcomes for patients requiring high-cost specialty therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioPlus Infusion.